DLGAP1-AS2: A Potential Drug Target and Biomarker (G84777)

Target Name: DLGAP1-AS2

NCBI ID: G84777

Other Name(s): DLGAP1 antisense RNA 2 | DLPAP1-AS2

DLGAP1-AS2: A Potential Drug Target and Biomarker

DLGAP1-AS2 (doublecortin-like growth factor-activated protein 1-aspartate) is a protein that is expressed in various tissues, including brain, heart, and pancreas, and has been implicated in several cellular processes. Its function in these processes, however, is not well understood, and its potential role in disease is also unclear. As a result, it is difficult to study, and any research on it has been limited.

Recent studies have identifiedDLGAP1-AS2 as a potential drug target and biomarker. Its unique structure and subcellular localization suggest that it may play a crucial role in the development and progression of certain diseases.

The Structure of DLGAP1-AS2

DLGAP1-AS2 is a 24.8 kDa protein that consists of two distinct domains: N-terminal and C-terminal. The N-terminal domain is rich in amino acids, including a calcified structure that is unique to this protein. The C-terminal domain is also rich in amino acids, but its structure is less well defined.

The protein is expressed in various tissues and has been shown to be highly expressed in the brain. It is also localized to the endoplasmic reticulum (ER) and to the nuclear pore complex (NPC), which are both important structures in the cell. These localizations suggest that DLGAP1-AS2 may be involved in the delivery and processing of proteins to the cell's cytoplasm.

Function and Implications

The function of DLGAP1-AS2 is not well understood, but its involvement in several cellular processes is known. It has been shown to be involved in the regulation of protein stability and in the detoxification of xenobiotics. It has also been shown to play a role in the development and progression of certain diseases, including cancer.

In addition to its role in disease, DLGAP1-AS2 may also be a potential drug target. Its unique structure and subcellular localization suggest that it may be difficult to target directly, but its function in the regulation of cellular processes may make it an attractive target for small molecules or antibodies that can modulate its activity.

Conclusion

DLGAP1-AS2 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and subcellular localization suggest that it may play a crucial role in the development and progression of certain diseases. Further research is needed to understand its function and implications, and to develop effective treatments for the diseases associated with its dysfunction.

Protein Name: DLGAP1 Antisense RNA 2

More Common Targets